Optellum Valuation Estimate
Optellum Valuation as of Last Funding Round
Optellum Company Overview
Optellum is a lung health company that has developed the world's first AI-based early lung cancer decision support software. The company's mission is to assist clinicians in the management, diagnosis, and care of patients with lung health issues. Optellum's team consists of machine learning, medical device, and clinical experts who collaborate with top hospitals and physicians. They have created a solution that leverages the largest real-world dataset of CT scans, employing artificial intelligence and machine learning to enable clinicians to identify at-risk patients and guide lung cancer management decisions
Optellum Valuation History
Optellum Stock Price
The stock price of Optellum can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Optellum has issued 250 million shares, at the estimated UpMarket valuation of $42.40 million, each share of Optellum stock would be worth $0.17.
Buy Optellum Stock
If you would like to buy shares in Optellum, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Optellum stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Optellum as well.
Optellum Management
| Name | Position |
|---|---|
| Johnathan WatkinsPhD | CEO |
| Jérôme Declerck | CTO |
| Peter Green | COO |
